keyword
https://read.qxmd.com/read/38673859/cardioprotection-and-suppression-of-fibrosis-by-diverse-cancer-and-non-cancer-cell-lines-in-a-murine-model-of-duchenne-muscular-dystrophy
#21
JOURNAL ARTICLE
Laris Achlaug, Irina Langier Goncalves, Ami Aronheim
The dynamic relationship between heart failure and cancer poses a dual challenge. While cardiac remodeling can promote cancer growth and metastasis, tumor development can ameliorate cardiac dysfunction and suppress fibrosis. However, the precise mechanism through which cancer influences the heart and fibrosis is yet to be uncovered. To further explore the interaction between heart failure and cancer, we used the MDX mouse model, which suffers from cardiac fibrosis and cardiac dysfunction. A previous study from our lab demonstrated that tumor growth improves cardiac dysfunction and dampens fibrosis in the heart and diaphragm muscles of MDX mice...
April 12, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38672797/gut-microbiome-and-its-role-in-valvular-heart-disease-not-a-gutted-relationship
#22
REVIEW
Gyanaranjan Nayak, Kyriakos Dimitriadis, Nikolaos Pyrpyris, Magdalini Manti, Nikolaos Kamperidis, Vasileios Kamperidis, Antonios Ziakas, Konstantinos Tsioufis
The role of the gut microbiome (GM) and oral microbiome (OM) in cardiovascular disease (CVD) has been increasingly being understood in recent years. It is well known that GM is a risk factor for various CVD phenotypes, including hypertension, dyslipidemia, heart failure and atrial fibrillation. However, its role in valvular heart disease (VHD) is less well understood. Research shows that, direct, microbe-mediated and indirect, metabolite-mediated damage as a result of gut dysbiosis and environmental factors results in a subclinical, chronic, systemic inflammatory state, which promotes inflammatory cell infiltration in heart valves and subsequently, via pro-inflammatory molecules, initiates a cascade of reaction, resulting in valve calcification, fibrosis and dysfunction...
April 19, 2024: Life
https://read.qxmd.com/read/38672459/transient-receptor-potential-canonical-5-trpc5-regulation-of-heart-rate-and-protection-against-pathological-cardiac-hypertrophy
#23
JOURNAL ARTICLE
Pratish Thakore, James E Clark, Aisah A Aubdool, Dibesh Thapa, Anna Starr, Paul A Fraser, Keith Farrell-Dillon, Elizabeth S Fernandes, Ian McFadzean, Susan D Brain
TRPC5 is a non-selective cation channel that is expressed in cardiomyocytes, but there is a lack of knowledge of its (patho)physiological role in vivo. Here, we examine the role of TRPC5 on cardiac function under basal conditions and during cardiac hypertrophy. Cardiovascular parameters were assessed in wild-type (WT) and global TRPC5 knockout (KO) mice. Despite no difference in blood pressure or activity, heart rate was significantly reduced in TRPC5 KO mice. Echocardiography imaging revealed an increase in stroke volume, but cardiac contractility was unaffected...
April 4, 2024: Biomolecules
https://read.qxmd.com/read/38672432/restoring-mitochondrial-function-and-muscle-satellite-cell-signaling-remedies-against-age-related-sarcopenia
#24
REVIEW
Emanuele Marzetti, Biliana Lozanoska-Ochser, Riccardo Calvani, Francesco Landi, Hélio José Coelho-Júnior, Anna Picca
Sarcopenia has a complex pathophysiology that encompasses metabolic dysregulation and muscle ultrastructural changes. Among the drivers of intracellular and ultrastructural changes of muscle fibers in sarcopenia, mitochondria and their quality control pathways play relevant roles. Mononucleated muscle stem cells/satellite cells (MSCs) have been attributed a critical role in muscle repair after an injury. The involvement of mitochondria in supporting MSC-directed muscle repair is unclear. There is evidence that a reduction in mitochondrial biogenesis blunts muscle repair, thus indicating that the delivery of functional mitochondria to injured muscles can be harnessed to limit muscle fibrosis and enhance restoration of muscle function...
March 28, 2024: Biomolecules
https://read.qxmd.com/read/38672089/sacubitril-valsartan-alleviates-cardiac-remodeling-and-dysfunction-in-l-name-induced-hypertension-and-hypertensive-heart-disease
#25
JOURNAL ARTICLE
Peter Stanko, Kristina Repova, Tomas Baka, Kristina Krajcirovicova, Silvia Aziriova, Andrej Barta, Stefan Zorad, Michaela Adamcova, Fedor Simko
There is ample evidence on the benefit of angiotensin receptor-neprilysin inhibitors (ARNIs) in heart failure, yet data regarding the potential protective action of ARNIs in hypertensive heart disease are sparse. The aim of this study was to show whether an ARNI exerts a protective effect in a model of Nω-nitro-L-arginine methyl ester (L-NAME)-induced hypertension with a hypertensive heart and to compare this potential benefit with an angiotensin-converting enzyme inhibitor, captopril. Five groups of adult male Wistar rats were studied (14 per group) for four weeks: untreated controls; ARNI (68 mg/kg/day); L-NAME (40 mg/kg/day); L-NAME treated with ARNI; and L-NAME treated with captopril (100 mg/kg/day)...
March 25, 2024: Biomedicines
https://read.qxmd.com/read/38670245/roles-of-ahr-cyp1s-signal-pathway-mediated-ros-production-in-uremic-cardiomyopathy
#26
JOURNAL ARTICLE
Wei Lu, Shi Cheng, Jiarui Xu, Zilong Xiao, Yong Yu, Qiwen Xie, Yi Fang, Ruizhen Chen, Bo Shen, Yeqing Xie, Xiaoqiang Ding
PURPOSE: Uremic cardiomyopathy (UCM) is the leading cause of chronic kidney disease (CKD) related mortality. Uremic toxins including indoxyl sulfate (IS) play important role during the progression of UCM. This study was to explore the underlying mechanism of IS related myocardial injury. METHODS: UCM rat model was established through five-sixths nephrectomy to evaluate its effects on blood pressure, cardiac impairment, and histological changes using echocardiography and histological analysis...
April 24, 2024: Toxicology Letters
https://read.qxmd.com/read/38669969/protective-effects-of-ginsenoside-f-2-on-isoproterenol-induced-myocardial-infarction-by-activating-the-nrf2-ho-1-and-pi3k-akt-signaling-pathways
#27
JOURNAL ARTICLE
Ying Cui, Jianfa Wu, Yanfang Wang, Dan Li, Furui Zhang, Xiaoman Jin, Meihui Li, Jing Zhang, Zhi Liu
BACKGROUND: Ginsenoside F2 (GF2 ) serves as the principal intestinal metabolite resulting from the oral intake of Panax ginseng and Panax quinquefolius, exhibiting antioxidative, hypolipidemic, antitumor, and anti-inflammatory properties. Nevertheless, its effect on myocardial infarction (MI) is still unknown. PURPOSE: The purpose of this study is to investigate the protective effect and the underlying mechanisms of GF2 against isoproterenol (ISO)-induced MI. METHODS: ISO-induced H9c2 cardiomyocytes and MI rat models were utilized as in vitro and in vivo models to evaluate the impact of anti-MI of GF2 ...
April 15, 2024: Phytomedicine
https://read.qxmd.com/read/38669371/the-potential-roles-of-exosomes-in-pathological-cardiomyocyte-hypertrophy-mechanisms-and-therapy-a-review
#28
REVIEW
Lijun Zhang, Fang Xie, Fengmei Zhang, Beiyao Lu
Pathological cardiac hypertrophy, characterized by the enlargement of cardiac muscle cells, leads to serious cardiac conditions and stands as a major global health issue. Exosomes, comprising small lipid bilayer vesicles, are produced by various cell types and found in numerous bodily fluids. They play a pivotal role in intercellular communication by transferring bioactive cargos to recipient cells or activating signaling pathways in target cells. Exosomes from cardiomyocytes, endothelial cells, fibroblasts, and stem cells are key in regulating processes like cardiac hypertrophy, cardiomyocyte survival, apoptosis, fibrosis, and angiogenesis within the context of cardiovascular diseases...
April 26, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38666825/enhanced-tfr1-recognition-of-myocardial-injury-after-acute-myocardial-infarction-with-cardiac-fibrosis-via-pre-degrading-excess-fibrotic-collagen
#29
JOURNAL ARTICLE
Wenwen Yang, Yueqi Wang, Hongzheng Li, Feifei Liao, Yuxuan Peng, Aimei Lu, Ling Tan, Hua Qu, Linzi Long, Changgeng Fu
The fibrosis process after myocardial infarction (MI) results in a decline in cardiac function due to fibrotic collagen deposition and contrast agents' metabolic disorders, posing a significant challenge to conventional imaging strategies in making heart damage clear in the fibrosis microenvironment. To address this issue, we developed an imaging strategy. Specifically, we pretreated myocardial fibrotic collagen with collagenase I combined with human serum albumin (HSA-C) and subsequently visualized the site of cardiac injury by near-infrared (NIR) fluorescence imaging using an optical contrast agent (CI, CRT-indocyanine green) targeting transferrin receptor 1 peptides (CRT)...
March 25, 2024: Biology
https://read.qxmd.com/read/38666458/serine-protease-inhibitor-serpina3n-regulates-cardiac-remodeling-after-myocardial-infarction
#30
JOURNAL ARTICLE
Qihao Sun, Wei Chen, Rimao Wu, Bo Tao, Ping Wang, Baiming Sun, Juan F Alvarez, Feiyang Ma, David Ceja Galindo, Sean P Maroney, Anthony J Saviola, Kirk C Hansen, Shen Li, Arjun Deb
Following myocardial infarction, the heart repairs itself via a fibrotic repair response. The degree of fibrosis is determined by the balance between deposition of extracellular matrix by activated fibroblasts and breakdown of nascent scar tissue by proteases that are secreted predominantly by inflammatory cells. Excessive proteolytic activity and matrix turnover has been observed in human heart failure and protease inhibitors in the injured heart regulate matrix breakdown. Serine protease inhibitors (Serpins) represent the largest and the most functionally diverse family of evolutionary conserved protease inhibitors and levels of the specific Serpin, SerpinA3, have been strongly associated with clinical outcomes in human myocardial infarction as well as non-ischemic cardiomyopathies...
April 26, 2024: Cardiovascular Research
https://read.qxmd.com/read/38666379/antiarrhythmic-and-anti-inflammatory-effects-of-sacubitril-valsartan-on-post-myocardial-infarction-scar
#31
JOURNAL ARTICLE
Daina Martínez-Falguera, Júlia Aranyó, Albert Teis, Gemma Ferrer-Curriu, Marta Monguió-Tortajada, Edgar Fadeuilhe, Oriol Rodríguez-Leor, Idoia Díaz-Güemes, Santiago Roura, Roger Villuendas, Axel Sarrias, Victor Bazan, Victoria Delgado, Antoni Bayes-Genis, Felipe Bisbal, Carolina Gálvez-Montón
BACKGROUND: Sacubitril/valsartan (Sac/Val) is superior to angiotensin-converting enzyme inhibitors in reducing the risk of heart failure hospitalization and cardiovascular death, but its mechanistic data on myocardial scar after myocardial infarction (MI) are lacking. The objective of this work was to assess the effects of Sac/Val on inflammation, fibrosis, electrophysiological properties, and ventricular tachycardia inducibility in post-MI scar remodeling in swine. METHODS: After MI, 22 pigs were randomized to receive β-blocker (BB; control, n=8) or BB+Sac/Val (Sac/Val, n=9)...
April 26, 2024: Circulation. Arrhythmia and Electrophysiology
https://read.qxmd.com/read/38664790/single-cell-insights-pioneering-an-integrated-atlas-of-chromatin-accessibility-and-transcriptomic-landscapes-in-diabetic-cardiomyopathy
#32
JOURNAL ARTICLE
Qiang Su, Wanzhong Huang, Yuan Huang, Rixin Dai, Chen Chang, Qiu-Yan Li, Hao Liu, Zhenhao Li, Yuxiang Zhao, Qiang Wu, Di-Guang Pan
BACKGROUND: Diabetic cardiomyopathy (DCM) poses a growing health threat, elevating heart failure risk in diabetic individuals. Understanding DCM is crucial, with fibroblasts and endothelial cells playing pivotal roles in driving myocardial fibrosis and contributing to cardiac dysfunction. Advances in Multimodal single-cell profiling, such as scRNA-seq and scATAC-seq, provide deeper insights into DCM's unique cell states and molecular landscape for targeted therapeutic interventions. METHODS: Single-cell RNA and ATAC data from 10x Multiome libraries were processed using Cell Ranger ARC v2...
April 25, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38664121/predictability-of-noninvasive-liver-fibrosis-score-for-cardiac-events-in-patients-with-nonalcoholic-fatty-liver-disease
#33
JOURNAL ARTICLE
Naoki Shibata, Takanori Ito, Hidenori Toyoda, Akihito Tanaka, Yasuhiro Morita, Yasunori Kanzaki, Naoki Watanabe, Naoki Yoshioka, Satoshi Yasuda, Itsuro Morishima
BACKGROUND AND AIMS: Patients with nonalcoholic fatty liver disease (NAFLD) have a higher risk of cardiac events. However, although the severity of liver fibrosis is related to worsening prognosis in patients with NAFLD, it is unclear whether the noninvasive liver fibrosis score has a predictive value for cardiac events. METHODS AND RESULTS: We evaluated 4071 patients with NAFLD diagnosed using ultrasonography. Liver fibrosis was assessed and divided into three groups based on the Fibrosis-4 (FIB4) index and NAFLD fibrosis score (NFS)...
March 27, 2024: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD
https://read.qxmd.com/read/38662612/salvianolic-acid-a-attenuates-angiotensin-ii-induced-cardiac-fibrosis-through-regulating-the-txnip-signaling-pathway
#34
JOURNAL ARTICLE
Huaqing Ye, Kaiyi Wang, Jiaxin Ma, Sumei Cui, Jialin Guo, Kehui Yang, Linmao Lyu
Cardiac fibrosis, characterized by excessive collagen accumulation in heart tissues, poses a significant clinical challenge in various heart diseases and complications. Although salvianolic acid A (Sal A) from Danshen (Salvia miltiorrhiza) has shown promise in the treatment of ischemic heart disease, myocardial infarction, and atherosclerosis, its effects on cardiac fibrosis remain unexplored. Our study investigated the efficacy of Sal A in reducing cardiac fibrosis and elucidated its underlying molecular mechanisms...
April 15, 2024: Shock
https://read.qxmd.com/read/38660786/sptlc3-is-essential-for-complex-i-activity-and-contributes-to-ischemic-cardiomyopathy
#35
JOURNAL ARTICLE
Anna Kovilakath, Adolfo G Mauro, Yolander Valentine, Frank Raucci, Maryam Jamil, Christiane Carter, Jeremy Thompson, Qun Chen, Beutner Gisela, Yang Yue, Jeremy Allegood, Xiaoxin X Wang, Jordan Dail, Teja Devarakonda, Komuraiah Myakala, Jolene J Windle, Mark A Subler, David Montefusco, Belinda Willard, Ali Javaheri, Tytus Bernas, Sushil K Mahata, Moshe Levi, Jinze Liu, George A Porter, Edward J Lesnefsky, Fadi N Salloum, L Ashley Cowart
BACKGROUND: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease contexts, and cellular roles are not completely understood. Sphingolipids are produced by the serine palmitoyltransferase enzyme, canonically composed of 2 subunits, SPTLC1 (serine palmitoyltransferase long chain base subunit 1) and SPTLC2 (serine palmitoyltransferase long chain base subunit 2)...
April 25, 2024: Circulation
https://read.qxmd.com/read/38660406/the-activation-of-lbh-cryab-signaling-promotes-cardiac-protection-against-i-r-injury-by-inhibiting-apoptosis-and-ferroptosis
#36
JOURNAL ARTICLE
Anbiao Wu, Chongbin Zhong, Xudong Song, Wen Yuan, Mintian Tang, Tao Shu, Houda Huang, Pingzhen Yang, Qicai Liu
Myocardial ischemia-reperfusion (I/R) injury stands out among cardiovascular diseases, and current treatments are considered unsatisfactory. For cardiomyocytes (CMs) in ischemic tissues, the upregulation of Limb-bud and Heart (LBH) and αB-crystallin (CRYAB) and their subsequent downregulation in the context of cardiac fibrosis have been verified in our previous research. Here, we focused on the effects and mechanisms of activated LBH-CRYAB signaling on damaged CMs during I/R injury, and confirmed the occurrence of mitochondrial apoptosis and ferroptosis during I/R injury...
May 17, 2024: IScience
https://read.qxmd.com/read/38660003/neurological-cardiac-musculoskeletal-and-renal-manifestations-of-scleroderma-along-with-insights-into-its-genetics-pathophysiology-diagnostic-and-therapeutic-updates
#37
JOURNAL ARTICLE
Priyadarshi Prajjwal, Mohammed Dheyaa Marsool Marsool, Vikas Yadav, Ramya S D Kanagala, Yeruva Bheemeswara Reddy, Jobby John, Justin Riley Lam, Nanditha Karra, Bita Amiri, Moiz Ul Islam, Venkatesh Nithya, Ali Dheyaa Marsool Marsool, Srikanth Gadam, Neel Vora, Omniat Amir Hussin
BACKGROUND: Scleroderma, also referred to as systemic sclerosis, is a multifaceted autoimmune condition characterized by abnormal fibrosis and impaired vascular function. Pathologically, it encompasses the persistent presence of inflammation, abnormal collagen buildup, and restructuring of blood vessels in various organs, resulting in a wide range of clinical symptoms. This review incorporates the most recent scientific literature on scleroderma, with a particular emphasis on its pathophysiology, clinical manifestations, diagnostic approaches, and treatment options...
April 2024: Health Science Reports
https://read.qxmd.com/read/38659956/loss-of-developmentally-derived-irf8-macrophages-promotes-hyperinnervation-and-arrhythmia-in-the-adult-zebrafish-heart
#38
Shannon E Paquette, Cliff I Oduor, Amy Gaulke, Sabina Stefan, Peter Bronk, Vanny Dafonseca, Nikolai Barulin, Cadence Lee, Rachel Carley, Alan R Morrison, Bum-Rak Choi, Jeffrey A Bailey, Jessica S Plavicki
Recent developments in cardiac macrophage biology have broadened our understanding of the critical functions of macrophages in the heart. As a result, there is further interest in understanding the independent contributions of distinct subsets of macrophage to cardiac development and function. Here, we demonstrate that genetic loss of interferon regulatory factor 8 (Irf8)-positive embryonic-derived macrophages significantly disrupts cardiac conduction, chamber function, and innervation in adult zebrafish. At 4 months post-fertilization (mpf), homozygous irf8st96/st96 mutants have significantly shortened atrial action potential duration and significant differential expression of genes involved in cardiac contraction...
April 20, 2024: bioRxiv
https://read.qxmd.com/read/38659739/functional-cardiac-consequences-of-%C3%AE-adrenergic-stress-induced-injury-in-the-mdx-mouse-model-of-duchenne-muscular-dystrophy
#39
Conner C Earl, Areli J Javier, Alyssa M Richards, Larry W Markham, Craig J Goergen, Steven S Welc
UNLABELLED: Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD), however, in the mdx mouse model of DMD, the cardiac phenotype differs from that seen in DMD-associated cardiomyopathy. Although some have used pharmacologic stress to enhance the cardiac phenotype in the mdx model, many methods lead to high mortality, variable cardiac outcomes, and do not recapitulate the structural and functional cardiac changes seen in human disease. Here, we describe a simple and effective method to enhance the cardiac phenotype model in mdx mice using advanced 2D and 4D high-frequency ultrasound to monitor cardiac dysfunction progression in vivo ...
April 20, 2024: bioRxiv
https://read.qxmd.com/read/38659015/human-umbilical-cord-derived-mesenchymal-stromal-cells-improve-myocardial-fibrosis-and-restore-mirna-133a-expression-in-diabetic-cardiomyopathy
#40
JOURNAL ARTICLE
Boxin Liu, Yan Wei, Jingjing He, Baofeng Feng, Yimeng Chen, Ruiyun Guo, Matthew D Griffin, Seán O Hynes, Sanbing Shen, Yan Liu, Huixian Cui, Jun Ma, Timothy O'Brien
BACKGROUND: Diabetic cardiomyopathy (DCM) is a serious health-threatening complication of diabetes mellitus characterized by myocardial fibrosis and abnormal cardiac function. Human umbilical cord mesenchymal stromal cells (hUC-MSCs) are a potential therapeutic tool for DCM and myocardial fibrosis via mechanisms such as the regulation of microRNA (miRNA) expression and inflammation. It remains unclear, however, whether hUC-MSC therapy has beneficial effects on cardiac function following different durations of diabetes and which mechanistic aspects of DCM are modulated by hUC-MSC administration at different stages of its development...
April 24, 2024: Stem Cell Research & Therapy
keyword
keyword
42023
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.